ULTRARUN
LIVE

Serial Number

79274572

Owner

QIAGEN GMBH

Attorney

Randolph E. Digges, III

Filing Date

Oct 15, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ULTRARUN Trademark

Serial Number: 79274572 • Registration: 6121360

ULTRARUN is a trademark filed by QIAGEN GMBH on October 15, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

October 15, 2019

Registration Date

August 11, 2020

Published for Opposition

May 26, 2020

Goods & Services

Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, namely, nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes

Chemical, biochemical and biotechnological diagnostic preparations used in science; non-medical reagents, enzymes and chemicals, namely, buffer solutions, used in analytical chemistry, for scientific and medical research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, and for the analysis of reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, and for the analysis of reagents, enzymes and buffer solutions for nucleic acid amplification and cloning

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 11, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 26, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 4, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 4, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 11, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 11, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 25, 2020 TROA
REFUSAL PROCESSED BY IB
Mar 13, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 21, 2020 RFCS
REFUSAL PROCESSED BY MPU
Feb 21, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 29, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jan 28, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 21, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 27, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 23, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 19, 2019 REPR